On Demand Learning

27 Results

  • Essentials: Stimulant Use Disorder

     Contains 4 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    Medical Certificate Medical AOA Category 1-B 1.00 0.00

    Review the diagnosis of stimulant use disorders.

  • Buprenorphine Induction for High Potency Synthetic Opioid Users

     Contains 3 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    Medical Certificate Medical AOA Category 1A 1.00 0.00
    Medical Certificate Medical AMA PRA Category 1 Credits™ 1.00 0.00
    Recorded On: 04/07/2021

    ORN Webinar Series: Presentation on the use of injectable buprenophrine for the treatment of Opioid Use Disorder (OUD) in patients using Highly Potent Synthetic Opioids (HPSO). This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Access to Buprenorphine Treatment for Opioid Use Disorder

     Contains 3 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    Medical Certificate Medical AOA Category 1A 1.00 0.00
    Medical Certificate Medical AMA PRA Category 1 Credits™ 1.00 0.00
    Recorded On: 03/24/2021

    ORN Webinar Series: A lecture covering the current landscape of buprenorphine treatment availability and ongoing issues is making this medication available, accessible and sustainable for all in need. This webinar has been approved for 1 AOA Category 1-A CME credits, and AOA designates this for a maximum of 1 AMA PRA Category 1 Credits™.

  • Q&A Session: Treatment of Perinatal Opioid Use Disorder via Telemedicine

     Contains 3 Component(s) Recorded On: 11/11/2020

    This is the sixth Q & A webinar in the telehealth series for the Opioid Response Network (ORN). Post your questions at: https://docs.google.com/document/d/1jWnx8vzasVmq_zIV9nLWIRr4qYJ14oiYHYr7w2HTd1w/edit?usp=sharing Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Treatment of Perinatal Opioid Use Disorder via Telemedicine

     Contains 3 Component(s) Recorded On: 11/04/2020

    This is the sixth webinar in the telehealth series for the Opioid Response Network (ORN). The webinar will describe the use of telemedicine to create integrated mental health and substance use disorder treatment services for pregnant and postpartum women receiving prenatal care in an obstetric setting. The webinar will describe outcomes for pregnant women with Opioid Use Disorder and how technology is being leveraged during COVID-19 to improve detection and treatment of maternal mental health and substance use disorders. Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Q&A Session: The Current Evidence On Telemedicine-Delivered Treatment for Opioid and Other Substance Use Disorders

     Contains 3 Component(s) Recorded On: 10/21/2020

    This is the fifth Q & A webinar in the telehealth series for the Opioid Response Network (ORN). Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or oganizations imply endorsement by the U.S. Government.

AOA Addiction Medicine Board Certification

Did you know that the AOA is now offering Certification in Addiction Medicine?

The next exam will be offered April 12-18, 2021 for both the initial and OCC (Recert) Addiction Medicine Certification Exam.
For registration and additional details about the exam, visit the AOA website.

Important Dates for the April 2021 Exam: 

  • February 26, 2021 - First application deadline
  • March 26, 2021 - Final application deadline

AOAAM's Board Certification Review Course

Now available on-demand and includes live Q&A Sessions:

Upcoming Live Q&A Sessions:

  • March 6, 2021 at 11:00 AM ET
  • March 27, 2021 at 11:00 AM ET

Learn more.

New to AOAAM

If you have not registered for one of our webinars in the past, please subscribe to AOAAM, then login and register for the webinars.